Interestingly, we found that the patients with a low cooperative ratio had a more aggressive malignancy in BC patients, and the cooperative ratio was correlated with the size of the tumor, pathological TNM stage, lymphatic metastasis, pathological stage, and HER-2 amplification. Here, ERBB2 is linked to breast cancer.